The drug "Nimica" describes the instruction as an agent that is part of the pharmacological group of anti-inflammatory drugs of the non-steroid type. The use of this medication has a pronounced analgesic and antipyretic effect on the patient's body. At the same time, the basis of the non-steroidal drug Nimika (the instructions for it confirms it) is the suppression of prostaglandin synthesis processes, a significant decrease in the severity of inflammatory manifestations directly in the pathological processes, blocking the release of free radicals and stimulating the reversible inhibition of the so-called prostaglandins of the E2 type. In addition, this analgesic has an overwhelming effect on
platelet aggregation.The anti-inflammatory and
antipyretic drug Nimika is produced (instructions must be in each package), mainly in the form of soluble tablets containing fifty or one hundred milligrams of nimesulide. It is this substance that acts as the main active element and has a pronounced analgesic effect. In addition, the composition of the tablets, which contain fifty milligrams of nimesulide, includes a banana flavor, and a hundred milligram dragee contains a fruit flavor.
The Nimika analgesic medication is recommended for use with the purpose of treating various inflammatory pathologies related to the musculoskeletal system, as well as treating the acute form of arthritis, rheumatoid arthritis and gout. In addition, doctors often prescribe this non-steroid drug to people with a diagnosis of enthesopathy.
For the relief of pain symptoms in inflammatory joint diseases, Nimika tablets are also excellent. The instruction recommends taking them during the treatment of fever of unclear etiology, treatment of migraine and headaches, osteoarthritis, inflammatory processes affecting the upper respiratory tract. And finally, the use of this analgesic non-steroidal drug is indicated in the postoperative period, as well as with injuries of soft tissues and musculoskeletal system.
The instruction categorically prohibits prescribing the Nimica antipyretic agent to patients under the age of twelve, as well as to all those who suffer from individual nimesulide intolerance. With severe violations in the work of the kidneys, a high level of acidity of the gastric juice and the presence of severe liver pathologies in a patient, this anti-inflammatory and analgesic drug should not be taken in the same way. In addition, the manufacturer does not recommend prescribing this medicine to women bearing a child. In the case of established ulcerative lesions of the digestive tract or peptic ulcer, it is also forbidden to use this non-steroidal drug.